The goal of this paper is to point out the role played by private equity investors (venture-capital companies and corporate investors) in the emergence of a new biotechnology industry in Germany in the second half of the 90?s. This analysis takes into account the different business models and...

In endogenous growth theory models have either increasing or constant ranges of product variety. Developments in modem biotechnology however show cases of increasing, decreasing or constant ranges of product variants. We present a simple endogenous growth model allowing for all of these three...

The German biotechnology industry missed the accession of this key technology in the 1980s. Policy makers make different efforts to overcome shortcomings and recent gaps. Public funding schemes have been implemented to establish a flourish biotech industry in Germany. We assume that R&D policy...